期刊
SURGICAL CLINICS OF NORTH AMERICA
卷 93, 期 5, 页码 1217-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.suc.2013.06.001
关键词
Allograft; Xenograft; Prosthetics; Efficacy
类别
After review and evaluation of current clinical data, including significant wound complications, a noteworthy failure rate at 1 year, and high product costs, it is difficult to support the continued use of biologic meshes in incisional hernia repair outside of well-designed and rigorously conducted clinical trials. An industry-sponsored, publicly available registry of biologic prosthetic use for ventral hernia repairs is needed. This straightforward mandate, if properly constructed and implemented, would significantly expand knowledge regarding how these intriguing biomaterials are used and their overall clinical efficacy, thus yielding a more robust basis for the continued use of biologic prosthetics in hernia repair than is currently available.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据